背景:COVID-19大流行的感染和死亡对服务不足的人群造成了不成比例的影响。需要一种社区参与的方法来支持围绕安全的COVID-19实践的决策,以促进公平获得检测和治疗。你和我:测试和治疗(YMTT)将评估一个系统的、可扩展的社区参与协议,该协议可快速访问COVID-19家庭测试,教育,关于下一步的指导,以及有关当地资源的信息,以促进服务不足人群的治疗。
方法:这项直接面向参与者的观察性研究将在家中进行,自我管理,指定社区人群的COVID-19检测试剂盒。YMTT具有公共卫生3.0框架和工具包,规定了社区参与的分层方法。我们将与两个大型社区组织合作,默塞德县联合之路(默塞德县,CA)和皮特县卫生局(皮特县,NC),谁将协调多达20个当地合作伙伴分发40,000个COVID测试和支持注册,同意,以及15个月内的数据收集。参与者将完成有关其人口统计的基线问题,有COVID-19感染的经验,以及对分发活动的满意度。社区合作伙伴还将完成参与调查。此外,参与者将获得关于COVID-19缓解和健康促进资源的指导,如果COVID-19检测呈阳性,则可以获得和负担得起的治疗方法。数据收集将使用基于网络的平台完成,该平台可以创建和管理电子数据捕获表格。实施措施包括评估1)工具包,作为形成社区-学术伙伴关系以获取COVID-19测试的方法,2)检测结果,和3)YMTT方案的功效与本地资源相结合,以提供测试信息,指导,治疗,和资源链接。研究结果将用于提供创新方法,以满足公共卫生研究中社区的需求,从而促进文化相关性,提高研究质量,促进卫生公平。
结论:这项工作将通过利用社区参与的研究工具包,促进服务不足人群获得COVID-19检测和治疗。该工具包的未来传播可以支持有效的社区-学术伙伴关系,以在服务不足的环境中进行健康干预。
背景:ClinicalTrials.gov标识符:NCT05455190。2022年7月13日注册。
Infections and deaths from the COVID-19 pandemic have disproportionately affected underserved populations. A community-engaged approach that supports decision making around safe COVID-19 practices is needed to promote equitable access to testing and treatment. You & Me: Test and Treat (YMTT) will evaluate a systematic and scalable community-engaged protocol that provides rapid access to COVID-19 at-home tests, education,
guidance on next steps, and information on local resources to facilitate treatment in underserved populations.
This direct-to-participant observational
study will distribute at-home, self-administered, COVID-19 testing kits to people in designated communities. YMTT features a Public Health 3.0 framework and Toolkit prescribing a tiered approach to community engagement. We will partner with two large community organizations, Merced County United Way (Merced County, CA) and Pitt County Health Department (Pitt County, NC), who will coordinate up to 20 local partners to distribute 40,000 COVID tests and support enrollment, consenting, and data collection over a 15-month period. Participants will complete baseline questions about their demographics, experience with COVID-19 infection, and satisfaction with the distribution event. Community partners will also complete engagement surveys. In addition, participants will receive
guidance on COVID-19 mitigation and health-promoting resources, and accessible and affordable therapeutics if they test positive for COVID-19. Data collection will be completed using a web-based platform that enables creation and management of electronic data capture forms. Implementation measures include evaluating 1) the Toolkit as a method to form community-academic partnerships for COVID-19 test access, 2) testing results, and 3) the efficacy of a YMTT protocol coupled with local resourcing to provide information on testing,
guidance, treatment, and links to resources. Findings will be used to inform innovative methods to address community needs in public health research that foster cultural relevance, improve research quality, and promote health equity.
This work will promote access to COVID-19 testing and treatment for underserved populations by leveraging a community-engaged research toolkit. Future dissemination of the toolkit can support effective community-academic partnerships for health interventions in underserved settings.
ClinicalTrials.gov Identifier: NCT05455190 . Registered 13 July 2022.